SMTL ID : 5ta8.1

Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 2 residues within 4Å: Chain A: H.106, C.225 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:C.225

1 x 79C: 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide(Non-covalent)

79C.2: 15 residues within 4Å: Chain A: F.71, L.72, G.73, C.80, E.82, A.93, K.95, V.127, L.143, E.144, L.145, C.146, R.147, R.149, F.196 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.72, A:L.72, A:F.196 Hydrogen bonds: A:L.72, A:C.146, A:C.146

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kiryanov, A. et al., Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors. Bioorg. Med. Chem. Lett. (2017)

Release Date

2017-02-22

Peptides

Serine/threonine-protein kinase PLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase PLK1

Related Entries With Identical Sequence